Phase II Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1-Pretreated Metastatic Non-Small Cell Lung Cancer and Metastatic Cutaneous Melanoma
Brentuximab Vedotin 与 Pembrolizumab 联合治疗 PD-1 治疗的转移性非小细胞肺癌和转移性皮肤黑色素瘤的 II 期开放标签试验
期刊:Clinical Cancer Research
影响因子:10
doi:10.1158/1078-0432.CCR-24-1478
Sylvia M Lee, Omid Hamid, Robert Jotte, Yousef Zakharia, Theresa Medina, Amanda Gillespie-Twardy, Inderjit Mehmi, Sunandana Chandra, Graham Watson, Patrick Ward, Marya Chaney, Hailing Lu, Jason Berndt, Brian P O'Connor, Kapil Rathi, Eeman Shaikh, Charles Lance Cowey3
